Publication | Closed Access
Phase I study of oral mitomycin C.
17
Citations
0
References
1976
Year
Oral Mitomycin CHealth SciencesMedicineGastrointestinal PharmacologyAntibiotic AdjuvantGastroenterologyAntimicrobial ResistancePeak Serum ConcentrationGastrointestinal AbsorptionOral MedicinePharmacotherapyAntimicrobial ChemotherapyPharmacologyPharmacokineticsDrug Resistance
This study demonstrates that the gastrointestinal absorption of oral mitomycin C is variable and that myelosuppression correlates most closely with the peak serum concentration. The probable maximal-tolerated dose of oral mitomycin C is 45-50 mg/m2.